This new EP Publication provides an epidemiological forecast for key types of conditions associated with cancer pain in the US market in 2008, 2013 and 2018.

This report presents expert analysis of the commercial potential and key differences among products in development for the treatment of cancer pain and describes the critical factors driving cancer pain market grown through 2018.

This NEW report includes an exclusive 30 page PowerPoint Presentation of the findings from Oncologist and Pain Clinician Interviews and a survey of 100 Pain Clinician Interviews. The summary of our qualitative in-depth discussions and quantitative survey provides quotes, and is a tremendously cost-effective supplement to any Marketing Research budget.

This new EP Publication provides an epidemiological forecast for key types of conditions associated with back pain in the US market in 2008, 2013 and 2018.

This report presents expert analysis of the commercial potential and key differences among products in development for the treatment of back pain and describes the critical factors driving cancer pain market grown through 2018.
This NEW report includes an exclusive 30 page PowerPoint Presentation of the findings from PCP and Pain Clinician Interviews and survey of 100 Pain Clinician Interviews. The summary of our qualitative in-depth discussions and quantitative survey provides quotes, and is a tremendously cost-effective supplement to any Marketing Research budget.

The Pain Clinic Monitor tracks prescriptions and treatments, as well as detailing in this key ‘point of care prescribing segment’ of the Pain Market – Pain Clinics. This segment represents high levels of prescribing intensity and new prescription initiation.

Click here to obtain: “Twelve Reasons to Subscribe to the Pain Clinic Monitor” – a list of reasons complied by those who have recognized its importance as a foundation to support their company’s efforts in this dynamic and changing market.

Today there are more than 2,000 free standing and university based clinics in the U.S., up from just 500 in 1998.

Sign up for the year, and you will obtain MONTHLY input, including access to the following:

» 10,000+ patients for 2008
» 27 Pain Condition Profiles
» Drugs prescribed (up to 7 per patient)
» Drugs administered in the office
» Drugs discontinued, and why
» 3,500+ Drug Detail Visits

Methodology: Monthly web-based survey of custom-built panel of 100 pre-screened pain clinics recruited from more than 2,000 pre-identified pain clinics. Representative of the entire population of pain clinics, as reported in a recent study profiling pain clinics, published in the Journal of Pain in 2007.

With this monitor you will be able to:

» Track in-office treatments and prescribed drugs
» Track detailing by company, product and message
» Assess the potential for new product opportunities
» Gain an understanding of the complete set of drugs prescribed for a given pain condition
» More effectively target your company’s Marketing, Promotional and Professional Education activities

This 4th edition of our well-received report on Neuropathic Pain draws upon WWMR’s Pain Clinic Monitor, for NEW details on treatment and office-visit frequency. As always, the report provides expert analysis and commentary on the future Neuropathic Pain market.

Epi-based projections of patient populations, and prescription-based estimates of the commercial value (USD) of this market in 2008, 2013, and 2018 are provided. These models incorporate the important features of key conditions associated with Neuropathic Pain:

» Neuropathic back pain
» Diabetic neuropathic
» Complex regional pain syndrome
» HIV/AIDS neuropathy
» Post-herpetic neuralgia
» Phantom limb pain
» Spinal cord injury
» Trigeminal neuralgia

Plus 2 NEW indications in 2008

» Fibromyalgia
» Neuropathic cancer pain